MedTrace Logo

Effect of Huperzine A on Cognitive Function and Perception of Effort During Exercise

NCT03445104 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2018-05-31

No results posted yet for this study

Summary

This study evaluates the effects of acute huperzine A ingestion prior to exercise on cognitive function and perceived effort in exercise-trained individuals. Huperzine A has shown the ability to improve cognitive function in dementia patients, and is currently marketed as a cognitive enhancing supplement. Study participants will receive either huperzine A or placebo during the first experimental session, and will receive the other substance during the second session.

Conditions

  • Cognitive Enhancement During Exercise

Interventions

OTHER

Huperzine A

During one of the two experimental sessions, participants will be given huperzine A.

OTHER

Placebo

During one of the two experimental sessions, participants will be given a placebo.

Sponsors & Collaborators

  • St. Louis University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-16
Primary Completion
2018-04-05
Completion
2018-04-05

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03445104 on ClinicalTrials.gov